| Due Diligence for Asset Managers |
|---|
|
You have viewed 10 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Lucid Diagnostics Inc | |
|---|---|
| Ticker | LUCD |
| CIK # | 0001799011 |
| CUSIP | 54948X109 |
| Sector | Life Sciences - Surgical & Medical Instruments & Apparatus |
| Address | One Grand Central Place, Suite 4600, New York, NY 10165 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Lucid Diagnostics Inc | 2024-12-06 | 21.9 M | Exemption: 506(b) · Duration: One year or less · Revenue: $1,000,001 - $5,000,000 |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001799011] | 10-K | |
| [0001799011] | 10-Q | |
| [0001799011] | 3 | |
| [0001799011] | 4 | |
| [0001799011] | 8-K | |
| [0001799011] | D | |
| [0001799011] | SC 13D | |
| [0001799011] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Ayrton Capital LLC | Lucid Diagnostics Inc | [2024-02-14] | 0.9 |
| Ayrton Capital LLC | Lucid Diagnostics Inc | [2023-03-23] | 0.99 |
| Pavmed Inc | Lucid Diagnostics Inc | [2021-10-27] | 75.5 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aklog Lishan
Common Stock
|
2026-02-20 | Grant | 2,170,000 | $0.00 | |
|
Matheis Dennis
Common Stock
|
2026-02-20 | Grant | 123,000 | $0.00 | |
|
White Debra
Common Stock
|
2026-02-20 | Grant | 123,000 | $0.00 | |
|
Sparks Ronald M
Common stock
|
2026-02-20 | Grant | 123,000 | $0.00 | |
|
Sokolov Jacque J
Common Stock
|
2026-02-20 | Grant | 123,000 | $0.00 | |
|
Palumbo John R
Common Stock
|
2026-02-20 | Grant | 123,000 | $0.00 | |
|
Lapidus Stanley
Common Stock
|
2026-02-20 | Grant | 123,000 | $0.00 | |
|
Cox James L
Common Stock
|
2026-02-20 | Grant | 123,000 | $0.00 | |
|
McGrath Dennis M
Common stock
|
2026-02-20 | Grant | 470,000 | $0.00 | |
|
O'Neil Shaun
Common stock
|
2026-02-20 | Grant | 620,000 | $0.00 | |
|
Gordon Michael Adam
Common stock
|
2026-02-20 | Grant | 300,000 | $0.00 | |
|
Palumbo John R
Employee stock option (right to buy) · derivative
|
2025-10-06 | Grant | 215,000 | $0.00 | |
|
Common Stock
|
2025-08-20 | Buy | 100,000 | $1.02 | 102,000 |
|
Matheis Dennis
Common Stock
|
2025-05-22 | Buy | 33,218 | $1.32 | 43,848 |
|
Common Stock
|
2025-05-22 | Buy | 33,218 | $1.32 | 43,848 |
|
Matheis Dennis
Common Stock
|
2025-05-21 | Buy | 129,684 | $1.32 | 171,183 |
|
Common Stock
|
2025-05-21 | Buy | 129,684 | $1.32 | 171,183 |
|
Matheis Dennis
Common Stock
|
2025-05-20 | Buy | 187,098 | $1.30 | 243,227 |
|
Common Stock
|
2025-05-20 | Buy | 187,098 | $1.30 | 243,227 |
|
Lapidus Stanley
Common Stock
|
2025-02-20 | Grant | 112,800 | $0.00 | |
| showing 20 of 81 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 103 | 35,617,133 |
| 2025-12-31 | 89 | 32,182,487 |
| 2025-09-30 | 86 | 35,205,577 |
| 2025-06-30 | 73 | 18,947,922 |
| 2025-03-31 | 50 | 9,387,363 |
| 2024-12-31 | 34 | 3,311,778 |
| 2024-09-30 | 30 | 2,453,466 |
| 2024-06-30 | 35 | 2,120,203 |
| 2024-03-31 | 31 | 2,073,289 |
| 2023-12-31 | 26 | 1,897,343 |
| 2023-09-30 | 25 | 1,915,169 |
| 2023-06-30 | 19 | 1,863,848 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Sequoia Financial Advisors LLC | [2026-06-30] | SOLE | 0 | 92,150 |
| Traphagen Investment Advisors LLC | [2026-06-30] | SOLE | 0 | 58,590 |
| Magnus Financial Group LLC | [2026-06-30] | SOLE | 0 | 55,400 |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 1,384 | 26,393 |
| Merit Financial Group LLC | [2026-06-30] | OTR | 0 | 7,115 |
| Merit Financial Group LLC | [2026-06-30] | SOLE | 9 | 2,900 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 241 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 239 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 235 | 235 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 157 | 157 |
| Gamma Investing LLC | [2026-06-30] | DFND | 142 | 142 | Prev | Page 1 | Next |